EUVIMEDEUVIMED entdecken
Open Access

IĸBζ as a Central Modulator of Inflammatory Arthritis Pathogenesis

Gaurav Swarnkar, Musarrat Naaz, Dorothy Mims, Prashant Gupta, Timothy Peterson, Matthew J Christopher, Srikanth Singamaneni, Gabriel Mbalaviele iD, Yousef Abu-Amer iD

Arthritis & Rheumatology · 2025-02 · 77 (2) · 124-139

DOI: 10.1002/art.42990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 27.10.2024. Verfasst von Gaurav Swarnkar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine, St. Louis, Missouri. Hauptthemen laut MEDLINE: Arthritis, Experimental, NF-kappa B, I-kappa B Kinase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIH HHS, NIH and National Institute of Arthritis and Musculoskeletal and Skin Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Current therapies targeting individual factors in inflammatory arthritis show variable efficacy, often requiring treatment with combinations of drugs, and are associated with undesirable side effects. NF‐ĸB is critical for the production and function of most inflammatory cytokines. However, given its essential role in physiologic processes, targeting NF‐ĸB is precarious. Hence, identifying pathways downstream of NF‐ĸB that selectively govern the expression of inflammatory cytokines in inflammatory arthritis would be advantageous. We have previously identified IĸBζ as a unique inflammatory signature of NF‐ĸB that controls the transcription of inflammatory cytokines only under pathologic conditions while sparing physiologic NF‐ĸB signals.

Methods

We generated mice harboring myeloid, lymphoid, and global deletion of Nfkbiz (the gene encoding IĸBζ). These models were subjected to serum transfer‐induced arthritis. Additionally, pharmacologic inhibitors of IĸBζ were injected intraperitonially. Joint swelling, microcomputed tomography, immunohistochemistry, flow cytometry, and cytokine measurements were conducted using synovial tissue samples.

Results

Global deletion of Nfkbiz or depletion of neutrophils (vastly IĸBζ + cells) reduced inflammatory synovial cells and increased anti‐inflammatory and regenerative synovial cells, plummeted expression of inflammatory factors and ameliorated experimental mouse inflammatory arthritis. Further, expression of immune responsive gene‐1, the enzyme responsible for itaconate production, was increased in synovial cells. Accordingly, the itaconate derivative dimethyl itaconate (DI) inhibited IĸBζ‐mediated inflammatory factors. Further, in silico screen identified 8‐hydroxyquinoline (HQ) as a putative inhibitor of IĸBζ not affecting physiologic NF‐ĸB activity. Congruently, systemic administration of either DI or HQ inhibited joint swelling and damage.

Conclusion

Our study positions IĸBζ as an inflammation‐specific target for therapeutic consideration in rheumatoid arthritis because its inhibition spares the beneficial functions of NF‐ĸB. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, ExperimentalNF-kappa BI-kappa B KinaseAnimalsMiceCytokinesSynovial MembraneDisease Models, AnimalX-Ray MicrotomographyAdaptor Proteins, Signal Transducing

Substanzen

Nfkbiz protein, mouseCytokinesNF-kappa BI-kappa B KinaseAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Washington University School of Medicine, St. Louis, Missouri.
  • Washington University in St. Louis, Missouri.
  • Washington University School of Medicine, HealthSpan Technologies, Inc., and Bioio, Inc., St. Louis, Missouri.
  • Washington University School of Medicine and Shriners Hospital for Children, St. Louis, Missouri.

ORCID-Profile: Gabriel Mbalaviele, Yousef Abu-Amer

Förderung

  • NIAMS NIH HHS
  • NIH HHS
  • NIH and National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • NIDDK NIH HHS
  • NIH Core Center for Musculoskeletal Biology and Medicine
  • NIGMS NIH HHS
  • NIA NIH HHS
  • Shriners Hospital for Children

Zitieren

APA

Swarnkar, G., Naaz, M., Mims, D., Gupta, P., Peterson, T., Christopher, M. J., Singamaneni, S., Mbalaviele, G., & Abu-Amer, Y. (2025). IĸBζ as a Central Modulator of Inflammatory Arthritis Pathogenesis. Arthritis & Rheumatology, 77(2), 124-139. https://doi.org/10.1002/art.42990

Vancouver

Swarnkar G, Naaz M, Mims D, Gupta P, Peterson T, Christopher MJ, et al. IĸBζ as a Central Modulator of Inflammatory Arthritis Pathogenesis. Arthritis & Rheumatology. 2025;77(2):124-139. doi:10.1002/art.42990

BibTeX
@article{Swarnkar2025,
  author = {Swarnkar, Gaurav and Naaz, Musarrat and Mims, Dorothy and Gupta, Prashant and Peterson, Timothy and Christopher, Matthew J and Singamaneni, Srikanth and Mbalaviele, Gabriel and Abu-Amer, Yousef},
  title = {IĸBζ as a Central Modulator of Inflammatory Arthritis Pathogenesis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {2},
  pages = {124--139},
  doi = {10.1002/art.42990}
}
Kostenlos starten →